The FDA recently reclassified pelvic mesh devices such as those at issue in the suits as high-risk devices. Read more
A state appeals court in New Jersey has upheld an $11.1 million jury award to a woman who claims a Johnson & Johnson unit’s vaginal mesh product caused debilitating nerve pain, say... Read more
According to the complaint, Ms. Carlino had Ethicon’s transvaginal mesh device, marketed as Gynecare TVT, implanted on Aug. 18, 2005. Read more
Johnson & Johnson was once a well-respected company in this country and in many circles it still is. But based on our firm’s litigation experience with this company, I am convinced that... Read more
The FDA says reported complications from transvaginal placement of surgical mesh for treatment of conditions including stress urinary incontinence and pelvic organ prolapse. Read more
A verdict of $13.5 million was returned against Johnson & Johnson’s Ethicon Inc. last month in Philadelphia. Read more
Judge Goodwin currently presides over seven MDLs against various transvaginal mesh manufacturers. Read more
Activity in our firm’s Mass Torts Section is at a record pace. Lawyers in the Section have been very busy on several fronts. They will investigate any potential claim involving a medication... Read more
As of Jan. 4, 2016, surgical mesh used to repair pelvic organ prolapse (POP) transvaginally, known as transvaginal mesh or TVM, has been reclassified by the U.S. Food and Drug Administration... Read more
C.R. Bard Inc. lost its appeal of a jury’s $2 million verdict in a bellwether trial that found the medical device maker liable for a woman’s injuries from defective vaginal mesh implants whe... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.